Coronavirus Update - 14th October 2020
Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.
We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement.
We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here
The challenge - To rapidly manufacture a GMP-compliant API-in-capsule product for use in Phase I and Phase II clinical trials. The product was being investigated for treatments spanning multiple therapeutic areas.
Find out more about how we solved the issue here
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.
